Skip to main content
. 2017 Sep 18;3:17063. doi: 10.1038/cddiscovery.2017.63

Figure 1.

Figure 1

Lauric acid inhibits the proliferation of breast and endometrial cancer cells. (a, b) Chemical structures of lauric acid (LA) and capric acid (CA). (bd) MTT growth assays in SkBr3 (c), Ishikawa (d) and MCF-10A (e) cells treated for 48 h with vehicle (−) or increasing concentrations of LA and CA, as indicated. Cell viability is expressed as the percentage of cells upon treatments respect to cells treated with vehicle. Values shown are mean±S.D. of three independent experiments performed in triplicate. (○) indicates P<0.05 for cells receiving vehicle versus treatments.